双相情感障碍
重性抑郁障碍
情绪障碍
精神科
萧条(经济学)
心情
医学
狂躁
精神障碍患病率
心理学
临床心理学
心理健康
焦虑
宏观经济学
经济
作者
Jeffrey J. Rakofsky,Mark Hyman Rapaport
出处
期刊:Continuum
[Lippincott Williams & Wilkins]
日期:2018-06-01
卷期号:24 (3): 804-827
被引量:56
标识
DOI:10.1212/con.0000000000000604
摘要
ABSTRACT PURPOSE OF REVIEW This article discusses the prevalence of the major mood disorders (major depressive disorder and bipolar disorder) in the community and within neurologic settings, articulates the steps taken to make a diagnosis of major depressive disorder or bipolar disorder, and reviews old and newer treatment options with proven efficacy for the treatment of these two conditions. RECENT FINDINGS New medications are available as treatment options for major depressive disorder and bipolar disorder, such as intranasal and IV ketamine, and somatic treatments, such as deep brain stimulation and vagal nerve stimulators, are being used to target treatment-resistant depression. SUMMARY Mood disorders are common in neurologic settings. They are disabling and increase morbidity and mortality. Clinicians should have a high index of suspicion if they suspect their patients seem more distressed or incapacitated than would be warranted by their neurologic disorders. If a patient does have a mood disorder, validating the patient’s experience, initiating treatment, and, if necessary, referring the patient to a primary care physician or psychiatrist are appropriate steps.
科研通智能强力驱动
Strongly Powered by AbleSci AI